We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Arno Therapeutics and Leica Biosystems Enters into a Co-development Agreement

News   Jan 08, 2014

 
Arno Therapeutics and Leica Biosystems Enters into a Co-development Agreement
 
 
Advertisement
 

RELATED ARTICLES

Study Finds Unique Genetic Variants in ADHD Patients From Different Ethnic Backgrounds

News

Researchers from Children’s Hospital of Philadelphia (CHOP) have shown there may be key genetic differences in the causes of attention-deficit hyperactivity disorder (ADHD) between African Americans and people of European ancestry, which may play an important part in how patients of different ethnic backgrounds respond to treatments for this condition.

READ MORE

CRISPR-Based Malaria Testing on the Fly

News

A multi-disciplinary research collaboration created a field-applicable, ultrasensitive diagnostic assay that specifically detects DNA sequences from all Plasmodium species in symptomatic and asymptomatic malaria.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE